Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma
The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issu...
Gespeichert in:
Veröffentlicht in: | Cancer science 2021-09, Vol.112 (9), p.3555-3568 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3568 |
---|---|
container_issue | 9 |
container_start_page | 3555 |
container_title | Cancer science |
container_volume | 112 |
creator | Fang, Yuanchang Chen, Geng Chen, Feng Hu, En Dong, Xiuqing Li, Zhenli He, Lei Sun, Yupeng Qiu, Liman Xu, Haipo Cai, Zhixiong Liu, Xiaolong |
description | The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC.
We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC. |
doi_str_mv | 10.1111/cas.15058 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A710748713</galeid><sourcerecordid>A710748713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</originalsourceid><addsrcrecordid>eNp1kl2P1CAUhhujcdfVC_8BiTd60VkolI8bk2biV7JZEz-uCaWns2xaqNCOmfjnpTMbdY3CBQSe9-W85BTFc4I3JI9La9KG1LiWD4pzQpkqBcb84XEvSoVpdVY8SekWY8qZYo-LM8qquqaKnxc_GmuXaGZAczQ-2eimOYyATEowtsMBtQd0bXyYQgT06bpBCb4t4K3zOxRhD2ZIyIc9DKhfvJ1d8Gb4wyoh59ENTGYOFoZhGUxE1sQsD6N5Wjzqsx6e3a0Xxde3b75s35dXH9992DZXpa0JkaWp-roD1koqOTGKQy17A4oYlhNbwgXtGZfWdparVgrbkRYTQXqOu7atCaUXxeuT77S0I3QWfC5w0FN0o4kHHYzT92-8u9G7sNeSYcWwzAYv7wxiyOnTrEeX1jzGQ1iSzp9JKoIrtaIv_kJvwxLzp6wUF0pIWuPf1M4MoJ3vQ37Xrqa6EQQLJsWx7s0_qDw7GJ0NHnqXz-8JXp0ENoaUIvS_MhKs107RuVP0sVMye3liv2eTw_9BvW0-nxQ_Af0cv9U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2567978350</pqid></control><display><type>article</type><title>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Fang, Yuanchang ; Chen, Geng ; Chen, Feng ; Hu, En ; Dong, Xiuqing ; Li, Zhenli ; He, Lei ; Sun, Yupeng ; Qiu, Liman ; Xu, Haipo ; Cai, Zhixiong ; Liu, Xiaolong</creator><creatorcontrib>Fang, Yuanchang ; Chen, Geng ; Chen, Feng ; Hu, En ; Dong, Xiuqing ; Li, Zhenli ; He, Lei ; Sun, Yupeng ; Qiu, Liman ; Xu, Haipo ; Cai, Zhixiong ; Liu, Xiaolong</creatorcontrib><description>The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC.
We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.15058</identifier><identifier>PMID: 34255396</identifier><language>eng</language><publisher>Tokyo: John Wiley & Sons, Inc</publisher><subject>Analysis ; Annotations ; Bioinformatics ; Blood clot ; CDO1 ; CYP2A6 ; DNA sequencing ; Genes ; Hepatocellular carcinoma ; Hepatoma ; Liver cancer ; Medical prognosis ; Messenger RNA ; Molecular modelling ; Nanopore sequencing ; novel transcript ; Nucleotide sequencing ; Original ; Patients ; Portal vein ; Proteins ; RNA sequencing ; Thrombosis ; Transcription ; Transcriptomes</subject><ispartof>Cancer science, 2021-09, Vol.112 (9), p.3555-3568</ispartof><rights>2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>COPYRIGHT 2021 John Wiley & Sons, Inc.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</citedby><cites>FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</cites><orcidid>0000-0002-3096-4981</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409408/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409408/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids></links><search><creatorcontrib>Fang, Yuanchang</creatorcontrib><creatorcontrib>Chen, Geng</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Hu, En</creatorcontrib><creatorcontrib>Dong, Xiuqing</creatorcontrib><creatorcontrib>Li, Zhenli</creatorcontrib><creatorcontrib>He, Lei</creatorcontrib><creatorcontrib>Sun, Yupeng</creatorcontrib><creatorcontrib>Qiu, Liman</creatorcontrib><creatorcontrib>Xu, Haipo</creatorcontrib><creatorcontrib>Cai, Zhixiong</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><title>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</title><title>Cancer science</title><description>The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC.
We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.</description><subject>Analysis</subject><subject>Annotations</subject><subject>Bioinformatics</subject><subject>Blood clot</subject><subject>CDO1</subject><subject>CYP2A6</subject><subject>DNA sequencing</subject><subject>Genes</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Liver cancer</subject><subject>Medical prognosis</subject><subject>Messenger RNA</subject><subject>Molecular modelling</subject><subject>Nanopore sequencing</subject><subject>novel transcript</subject><subject>Nucleotide sequencing</subject><subject>Original</subject><subject>Patients</subject><subject>Portal vein</subject><subject>Proteins</subject><subject>RNA sequencing</subject><subject>Thrombosis</subject><subject>Transcription</subject><subject>Transcriptomes</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kl2P1CAUhhujcdfVC_8BiTd60VkolI8bk2biV7JZEz-uCaWns2xaqNCOmfjnpTMbdY3CBQSe9-W85BTFc4I3JI9La9KG1LiWD4pzQpkqBcb84XEvSoVpdVY8SekWY8qZYo-LM8qquqaKnxc_GmuXaGZAczQ-2eimOYyATEowtsMBtQd0bXyYQgT06bpBCb4t4K3zOxRhD2ZIyIc9DKhfvJ1d8Gb4wyoh59ENTGYOFoZhGUxE1sQsD6N5Wjzqsx6e3a0Xxde3b75s35dXH9992DZXpa0JkaWp-roD1koqOTGKQy17A4oYlhNbwgXtGZfWdparVgrbkRYTQXqOu7atCaUXxeuT77S0I3QWfC5w0FN0o4kHHYzT92-8u9G7sNeSYcWwzAYv7wxiyOnTrEeX1jzGQ1iSzp9JKoIrtaIv_kJvwxLzp6wUF0pIWuPf1M4MoJ3vQ37Xrqa6EQQLJsWx7s0_qDw7GJ0NHnqXz-8JXp0ENoaUIvS_MhKs107RuVP0sVMye3liv2eTw_9BvW0-nxQ_Af0cv9U</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Fang, Yuanchang</creator><creator>Chen, Geng</creator><creator>Chen, Feng</creator><creator>Hu, En</creator><creator>Dong, Xiuqing</creator><creator>Li, Zhenli</creator><creator>He, Lei</creator><creator>Sun, Yupeng</creator><creator>Qiu, Liman</creator><creator>Xu, Haipo</creator><creator>Cai, Zhixiong</creator><creator>Liu, Xiaolong</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3096-4981</orcidid></search><sort><creationdate>202109</creationdate><title>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</title><author>Fang, Yuanchang ; Chen, Geng ; Chen, Feng ; Hu, En ; Dong, Xiuqing ; Li, Zhenli ; He, Lei ; Sun, Yupeng ; Qiu, Liman ; Xu, Haipo ; Cai, Zhixiong ; Liu, Xiaolong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Annotations</topic><topic>Bioinformatics</topic><topic>Blood clot</topic><topic>CDO1</topic><topic>CYP2A6</topic><topic>DNA sequencing</topic><topic>Genes</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Liver cancer</topic><topic>Medical prognosis</topic><topic>Messenger RNA</topic><topic>Molecular modelling</topic><topic>Nanopore sequencing</topic><topic>novel transcript</topic><topic>Nucleotide sequencing</topic><topic>Original</topic><topic>Patients</topic><topic>Portal vein</topic><topic>Proteins</topic><topic>RNA sequencing</topic><topic>Thrombosis</topic><topic>Transcription</topic><topic>Transcriptomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fang, Yuanchang</creatorcontrib><creatorcontrib>Chen, Geng</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Hu, En</creatorcontrib><creatorcontrib>Dong, Xiuqing</creatorcontrib><creatorcontrib>Li, Zhenli</creatorcontrib><creatorcontrib>He, Lei</creatorcontrib><creatorcontrib>Sun, Yupeng</creatorcontrib><creatorcontrib>Qiu, Liman</creatorcontrib><creatorcontrib>Xu, Haipo</creatorcontrib><creatorcontrib>Cai, Zhixiong</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fang, Yuanchang</au><au>Chen, Geng</au><au>Chen, Feng</au><au>Hu, En</au><au>Dong, Xiuqing</au><au>Li, Zhenli</au><au>He, Lei</au><au>Sun, Yupeng</au><au>Qiu, Liman</au><au>Xu, Haipo</au><au>Cai, Zhixiong</au><au>Liu, Xiaolong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</atitle><jtitle>Cancer science</jtitle><date>2021-09</date><risdate>2021</risdate><volume>112</volume><issue>9</issue><spage>3555</spage><epage>3568</epage><pages>3555-3568</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC.
We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.</abstract><cop>Tokyo</cop><pub>John Wiley & Sons, Inc</pub><pmid>34255396</pmid><doi>10.1111/cas.15058</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-3096-4981</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-9032 |
ispartof | Cancer science, 2021-09, Vol.112 (9), p.3555-3568 |
issn | 1347-9032 1349-7006 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409408 |
source | DOAJ Directory of Open Access Journals; Access via Wiley Online Library; Wiley Online Library (Open Access Collection); PubMed Central |
subjects | Analysis Annotations Bioinformatics Blood clot CDO1 CYP2A6 DNA sequencing Genes Hepatocellular carcinoma Hepatoma Liver cancer Medical prognosis Messenger RNA Molecular modelling Nanopore sequencing novel transcript Nucleotide sequencing Original Patients Portal vein Proteins RNA sequencing Thrombosis Transcription Transcriptomes |
title | Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A07%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accurate%20transcriptome%20assembly%20by%20Nanopore%20RNA%20sequencing%20reveals%20novel%20functional%20transcripts%20in%20hepatocellular%20carcinoma&rft.jtitle=Cancer%20science&rft.au=Fang,%20Yuanchang&rft.date=2021-09&rft.volume=112&rft.issue=9&rft.spage=3555&rft.epage=3568&rft.pages=3555-3568&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.15058&rft_dat=%3Cgale_pubme%3EA710748713%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2567978350&rft_id=info:pmid/34255396&rft_galeid=A710748713&rfr_iscdi=true |